Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Singapore finalises guide on fast-track registration of Class B devices ahead of 1 Sept launch

This article was originally published in Clinica

Executive Summary

Singapore's Health Sciences Authority has issued final guidance and a related explanatory document on two fast-track registration schemes for Class B devices (low-moderate risk) that will be launched on 1 September.

You may also be interested in...



Launch Of EU Clinical Trial Portal Moves A Step Closer

An independent audit of the new EU Clinical Trials Information System has finally commenced, indicating that plans are on track for the EU Clinical Trial Regulation to be implemented from December 2021.

EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines

EU regulators have agreed on supplementary pharmacovigilance requirements applicable to COVID-19 vaccines following approval.

UK Explains How To Build COVID-19 Resilience Into Trial Design

The UK Medicines and Healthcare products Regulatory Agency wants clinical trial sponsors to integrate available regulatory flexibilities into normal practice so that their studies can withstand further potential disruptions from the COVID-19 pandemic.

Topics

UsernamePublicRestriction

Register

LL1134786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel